Literature DB >> 11920422

High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.

Sarah Bingham1, Douglas Veale, Ursula Fearon, John D Isaacs, Gareth Morgan, Paul Emery, Dennis McGonagle, Richard Reece, Roy Clague, John A Snowden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11920422     DOI： 10.1002/art.10093

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

1.  Stem cell therapy: resetting autoimmunity or postponing the inevitable?

Authors:  Jacob M van Laar
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-06       Impact factor: 5.346

Review 2.  Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.

Authors:  A Tyndall; R Saccardi
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

3.  Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.

Authors:  R J Verburg; R Flierman; J K Sont; F Ponchel; L van Dreunen; E W Levarht; M M Welling; R E M Toes; J D Isaacs; J M van Laar
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

4.  Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Authors:  J A Snowden; R Saccardi; M Allez; S Ardizzone; R Arnold; R Cervera; C Denton; C Hawkey; M Labopin; G Mancardi; R Martin; J J Moore; J Passweg; C Peters; M Rabusin; M Rovira; J M van Laar; D Farge
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

5.  Thymic function in juvenile idiopathic arthritis.

Authors:  A R Lorenzi; T A Morgan; A Anderson; J Catterall; A M Patterson; H E Foster; J D Isaacs
Journal:  Ann Rheum Dis       Date:  2008-07-15       Impact factor: 19.103

6.  Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells.

Authors:  Daniel S Pharoah; Hemlata Varsani; Richard W Tatham; Katy R Newton; Wilco de Jager; Berent J Prakken; Nigel Klein; Lucy R Wedderburn
Journal:  Arthritis Res Ther       Date:  2006-02-28       Impact factor: 5.156

7.  Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.

Authors:  Frederique Ponchel; Robert J Verburg; Sarah J Bingham; Andrew K Brown; John Moore; Andrew Protheroe; Kath Short; Catherine A Lawson; Ann W Morgan; Mark Quinn; Maya Buch; Sarah L Field; Sarah L Maltby; Aurelie Masurel; Susan H Douglas; Liz Straszynski; Ursula Fearon; Douglas J Veale; Poulam Patel; Dennis McGonagle; John Snowden; Alexander F Markham; David Ma; Jacob M van Laar; Helen A Papadaki; Paul Emery; John D Isaacs
Journal:  Arthritis Res Ther       Date:  2004-11-16       Impact factor: 5.156

Review 8.  Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: A systematic review and meta-analysis.

Authors:  Xiao Qiu; Jue-Rong Feng; Li-Ping Chen; Shi Liu; Meng Zhang; Zhou Zhou; Jing Liu; Qiu Zhao
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 9.  Update on mesenchymal stem cell-based therapy in lupus and scleroderma.

Authors:  Audrey Cras; Dominique Farge; Thierry Carmoi; Jean-Jacques Lataillade; Dan Dan Wang; Lingyun Sun
Journal:  Arthritis Res Ther       Date:  2015-11-03       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.